Long-term safety and efficacy of long-acting pasireotide in acromegaly

被引：0
作者：
Amit Akirov
Alexander Gorshtein
Idit Dotan
Nariman Saba Khazen
Yulia Pauker
Michal Gershinsky
Ilan Shimon
机构：
[1] Beilinson Hospital,Institute of Endocrinology
[2] Tel-Aviv University,Sackler School of Medicine
[3] Clalit Medical Services,Linn Medical Center
来源：
Endocrine | 2021年 / 74卷
关键词：
Acromegaly; Growth hormone; Hyperglycemia; Pasireotide LAR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：396 / 403
页数：7
相关论文
共 50 条
  • [41] Efficacy and safety of fractionated conformal radiation therapy in acromegaly: a long-term follow-up study
    Baldomero Gonzales-Virla
    Guadalupe Vargas-Ortega
    Karen-Belen Martínez-Vázquez
    Ana Laura Espinosa de lo Monteros
    Ernesto Sosa-Erosa
    Blas López-Félix
    Victoria Mendoza-Zubieta
    Moisés Mercado
    Endocrine, 2019, 65 : 386 - 392
  • [42] TREATMENT OF ACROMEGALY WITH A LONG-ACTING FORMULATION OF LANREOTIDE - A NEW SOMATOSTATIN ANALOG
    HERON, I
    THOMAS, F
    DERO, M
    POUTRAIN, JR
    HENANE, S
    CATUS, F
    KUHN, JM
    PRESSE MEDICALE, 1993, 22 (11): : 526 - 531
  • [43] Assessment of long-term remission of acromegaly following surgery
    Krieger, MD
    Couldwell, WT
    Weiss, MH
    JOURNAL OF NEUROSURGERY, 2003, 98 (04) : 719 - 724
  • [44] Persistent remission of acromegaly in a patient with GH-secreting pituitary adenoma: Effect of treatment with pasireotide long-acting release and consequence of treatment withdrawal
    Yu, Na
    Wang, Linjie
    Yang, Hongbo
    Pan, Hui
    Duan, Lian
    Zhu, Huijuan
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (06) : 835 - 840
  • [45] Short- and long-term glycemic effects of pasireotide in patients with acromegaly: a comprehensive case study with review of literature
    Taki, Yuki
    Kono, Takashi
    Matsuda, Tatsuma
    Kozu, Ryunosuke
    Fujimoto, Masanori
    Sakuma, Ikki
    Hashimoto, Naoko
    Horiguchi, Kentaro
    Higuchi, Yoshinori
    Tanaka, Tomoaki
    ENDOCRINE JOURNAL, 2025, : 421 - 435
  • [46] Efficacy of the new long-acting formulation of lanreotide (Lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly
    G. Lombardi
    F. Minuto
    G. Tamburrano
    M. R. Ambrosio
    G. Arnaldi
    M. Arosio
    V. Chiarini
    R. Cozzi
    S. Grottoli
    F. Mantero
    F. Bogazzi
    M. Terzolo
    P. Tita
    P. F. Boscani
    A. Colao
    Journal of Endocrinological Investigation, 2009, 32 : 202 - 209
  • [47] Octreotide long-acting release (LAR) - A review of its use in the management of acromegaly
    McKeage, K
    Cheer, S
    Wagstaff, AJ
    DRUGS, 2003, 63 (22) : 2473 - 2499
  • [48] Therapeutic innovations in endocrine diseases - Part 4: Pasireotide: Long-acting release somatostatin analogue
    Wemeau, Jean-Louis
    PRESSE MEDICALE, 2016, 45 (06): : E217 - E220
  • [49] Acromegaly Update on Management and Long-Term Morbidities
    Kasuki, Leandro
    Antunes, Ximene
    Lamback, Elisa Baranski
    Gadelha, Monica R.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2020, 49 (03) : 475 - +
  • [50] Long-term effects of pegvisomant in patients with acromegaly
    Hodish, Israel
    Barkan, Ariel
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (06): : 324 - 332
12345